Amundi’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $731K | Buy |
10,274
+3,618
| +54% | +$257K | ﹤0.01% | 1267 |
|
|
2025
Q1 | $492K | Sell |
6,656
-25,635
| -79% | -$1.89M | ﹤0.01% | 1491 |
|
|
2024
Q4 | $2.15M | Sell |
32,291
-15,780
| -33% | -$1.05M | ﹤0.01% | 1172 |
|
|
2024
Q3 | $3.7M | Buy |
48,071
+3,215
| +7% | +$247K | ﹤0.01% | 1039 |
|
|
2024
Q2 | $3.44M | Sell |
44,856
-57,915
| -56% | -$4.45M | ﹤0.01% | 1017 |
|
|
2024
Q1 | $7.03M | Buy |
102,771
+25,076
| +32% | +$1.71M | ﹤0.01% | 901 |
|
|
2023
Q4 | $5.35M | Buy |
77,695
+74,670
| +2,468% | +$5.15M | ﹤0.01% | 968 |
|
|
2023
Q3 | $204K | Sell |
3,025
-353,049
| -99% | -$23.8M | ﹤0.01% | 1590 |
|
|
2023
Q2 | $23.2M | Buy |
356,074
+33,862
| +11% | +$2.21M | 0.01% | 667 |
|
|
2023
Q1 | $23.2M | Buy |
322,212
+1,376
| +0.4% | +$99.1K | 0.01% | 677 |
|
|
2022
Q4 | $22.6M | Sell |
320,836
-4,788
| -1% | -$337K | 0.01% | 674 |
|
|
2022
Q3 | $18.5M | Sell |
325,624
-89,278
| -22% | -$5.06M | 0.01% | 710 |
|
|
2022
Q2 | $27M | Sell |
414,902
-20,312
| -5% | -$1.32M | 0.02% | 561 |
|
|
2022
Q1 | $30.9M | Buy |
435,214
+27,823
| +7% | +$1.98M | 0.02% | 569 |
|
|
2021
Q4 | $23.7M | Sell |
407,391
-261,062
| -39% | -$15.2M | 0.02% | 645 |
|
|
2021
Q3 | $40.1M | Sell |
668,453
-144,866
| -18% | -$8.7M | 0.03% | 510 |
|
|
2021
Q2 | $48.7M | Buy |
+813,319
| New | +$48.7M | 0.03% | 449 |
|